Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204
Jerome C. Landry, Yang Feng, Steven J. Cohen, Charles A. Staley, Richard Whittington, Elin Ruth Sigurdson, Halla Nimeiri, Udit Verma, Roshan S. Prabhu, Al Bowen Benson
Research output: Contribution to journal › Article › peer-review
49Scopus
citations
Fingerprint
Dive into the research topics of 'Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204'. Together they form a unique fingerprint.